Comparison of the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio Alone versus a Multi-Marker Regression Model for the Prediction of Preeclampsia-Related Adverse Outcomes after 34 Weeks of Gestation
Authors:
- Dorota SrokaDSDorota Sroka
- Lisa-Antonia Lorenz-MeyerLLLisa-Antonia Lorenz-Meyer
- Valerie ScherfeldVSValerie Scherfeld
- Julie ThomaJTJulie Thoma
- Andreas BusjahnABAndreas Busjahn
- Wolfgang HenrichWHWolfgang Henrich
- Stefan VerlohrenSVStefan Verlohren
- 21 February 2023
- journal article
- research article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 50 (3) , 215-224
Abstract
Introduction: The objective of this retrospective study was to compare the predictive performance of the soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio alone or in a multi-marker regression model for preeclampsia-related maternal and/or fetal adverse outcomes in women >34 weeks of gestation. Methods: We analyzed the data collected from 655 women with suspected preeclampsia. Adverse outcomes were predicted by multivariable and univariable logistic regression models. The outcome of patients was evaluated within 14 days after presentation with signs and symptoms of preeclampsia or diagnosed preeclampsia. Results: The full model integrating available, standard clinical information and the sFlt-1/PlGF ratio had the best predictive performance for adverse outcomes with an AUC of 72.6%, which corresponds to a sensitivity of 73.3% and specificity of 66.0%. The positive predictive value of the full model was 51.4%, and the negative predictive value was 83.5%. 24.5% of patients, who did not experience adverse outcomes but were classified as high risk by sFlt-1/PlGF ratio (≥38), were correctly classified by the regression model. The sFlt-1/PlGF ratio alone had a significantly lower AUC of 65.6%. Conclusions: Integrating angiogenic biomarkers in a regression model improved the prediction of preeclampsia-related adverse outcomes in women at risk after 34 weeks of gestation.Keywords
This publication has 37 references indexed in Scilit:
- Clinical characterization and outcomes of preeclampsia with normal angiogenic profileHypertension in Pregnancy, 2013
- Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected PreeclampsiaCirculation, 2012
- Angiogenic growth factors in the diagnosis and prediction of pre-eclampsiaClinical Science, 2011
- Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusionThe Journal of Maternal-Fetal & Neonatal Medicine, 2011
- Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS modelThe Lancet, 2011
- An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2010
- Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestationAmerican Journal of Obstetrics and Gynecology, 2004
- Prediction of adverse outcomes by common definitions of hypertension in pregnancyObstetrics & Gynecology, 2001
- The preterm prediction study: Risk factors for indicated preterm birthsAmerican Journal of Obstetrics and Gynecology, 1998
- Intrauterine growth curves based on ultrasonically estimated foetal weightsActa Paediatrica, 1996